Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-15 Sale | 2024-07-17 2:50 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 33,848 | $11.72 | $396,699 | 381,574 (Indirect Direct) | View |
| 2024-03-22 Sale | 2024-03-26 4:05 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 16,851 | $9.11 | $153,513 | 414,624 (Indirect Direct) | View |
| 2023-04-06 Purchase | 2023-04-07 3:19 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 12,919 | $7.8199 | $101,025 | 190,526 (Indirect Direct) | View |
| 2023-03-01 Sale | 2023-03-03 6:59 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 1,436 | $8.5411 | $12,265 | 177,607 (Indirect Direct) | View |
| 2023-01-20 Sale | 2023-01-20 7:39 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 5,821 | $8.1995 | $47,729 | 341,543 (Indirect Direct) | View |
| 2022-11-21 Sale | 2022-11-23 4:07 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 1,526 | $9.6 | $14,650 | 85,956 (Indirect Direct) | View |
| 2022-05-13 Purchase | 2022-05-16 8:45 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 20,500 | $7.4066 | $151,835 | 65,319 (Indirect Direct) | View |
| 2021-09-09 Sale | 2021-09-13 4:11 pm | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 4,850 | $25.58 | $124,063 | 5,250 (Direct) | View |
| 2021-09-01 Sale | 2021-09-03 4:25 pm | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 48,508 | $25.02 | $1,213,814 | 57,335 (Direct) | View |
| 2021-03-22 Sale | 2021-03-23 7:22 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 11,513 | $43.32 | $498,751 | 855,687 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-14 Option Award | 2024-06-18 4:52 pm | N/A 2034-06-14 | Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director | 37,191 | $0 | 45,878 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-22 8:19 pm | N/A 2034-01-17 | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 475,000 | $0 | 475,000 (Direct) | View |
| 2023-11-01 Option Award | 2023-11-03 4:53 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 37,500 | $0 | 430,751 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-17 5:00 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 200,000 | $0 | 393,251 (Direct) | View |
| 2023-07-14 Disposition | 2023-07-17 5:00 pm | N/A 2030-06-30 | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 400,000 | $0 | 393,251 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 7:10 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director | 16,595 | $0 | 20,907 (Direct) | View |
| 2023-03-10 Disposition | 2023-03-10 09:27 am | N/A 2026-11-14 | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 141,622 | $0 | 0 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-20 7:39 pm | N/A 2033-01-18 | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 260,000 | $0 | 341,543 (Direct) | View |
| 2022-10-26 Option Award | 2022-10-28 4:45 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 9,859 | $0 | 9,859 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-02 4:05 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 7,500 | $0 | 87,482 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:58 pm | N/A 2032-06-01 | Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director | 16,108 | $0 | 16,108 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 5:14 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 12,000 | $0 | 77,319 (Direct) | View |
| 2022-01-19 Option Award | 2022-01-21 6:47 pm | N/A 2032-01-18 | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 247,500 | $0 | 250,809 (Direct) | View |
| 2021-11-05 Option Award | 2021-11-09 5:40 pm | N/A 2031-11-04 | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 21,096 | $0 | 21,096 (Direct) | View |
| 2021-09-09 Exercise | 2021-09-13 4:11 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 4,850 | $7.65 | 5,250 (Direct) | View |
| 2021-09-09 Exercise | 2021-09-13 4:11 pm | N/A 2029-08-23 | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 4,850 | $0 | 5,250 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-03 4:25 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 48,508 | $7.65 | 57,335 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-03 4:25 pm | N/A 2029-08-23 | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 48,508 | $0 | 57,335 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:36 pm | N/A 2031-06-09 | Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director | 13,391 | $0 | 13,391 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-23 7:22 pm | N/A 2029-08-28 | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 11,513 | $0 | 855,687 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-23 7:22 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 11,513 | $6.95 | 855,687 (Direct) | View |
| 2021-01-28 Option Award | 2021-01-29 4:27 pm | N/A 2031-01-27 | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 225,000 | $0 | 225,000 (Direct) | View |
| 2020-11-02 Option Award | 2020-11-04 4:34 pm | N/A 2030-11-02 | Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2020-09-15 Option Award | 2020-09-17 4:16 pm | N/A 2030-09-14 | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 21,603 | $0 | 21,603 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-02 4:44 pm | N/A 2030-06-30 | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 175,000 | $0 | 175,000 (Direct) | View |
| 2019-11-20 Disposition | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | 43,745 | $0 | 0 (Direct) | View |
| 2019-11-20 Option Award | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | 32,868 | $0 | 0 (Direct) | View |
| 2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2023-05-01 | CELGENE CORP | CELG | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | 175,619 | $0 | 0 (Direct) | View |